In a groundbreaking move for Canadian healthcare, CHU Sainte-Justine and the Hospital for Sick Children (SickKids) are combining forces to revolutionize the future of paediatric medicine in this country, with the support of a $50 million investment from the Azrieli Foundation. Directing the funds to the advancement of Precision Child Health, the unprecedented partnership will establish a discovery and research pipeline between Canada’s top paediatric hospitals, resulting in better outcomes, improved quality of life and tailored medical care for children across the country.
The significance of this partnership lies in the scale and ambition of the working relationship. SickKids and CHU Sainte-Jutsine are two of North America’s largest child health research hospitals, with combined coverage of 61 per cent of Canada’s paediatric population. Together, they treat the majority of acute paediatric cases countrywide. Further, these internationally recognized institutions will focus their ambitions on three innovation pillars: genomics, novel therapies, and rich research data.
Precision Child Health uses information about a child’s genes, biology, environment, and social determinants to predict, prevent, diagnose and treat disease in a more targeted and individualized way. The approach also has dramatic implications for children’s long-term health into adulthood.
The Azrieli Foundation first invested $2.6 million in seed funding two years ago to allow the partners to establish the required frameworks for governance, legal agreements, engagement of patient partners, and ethical considerations. With these frameworks in place, the Foundation has now invested an additional $50 million to accelerate this transformational vision for personalized child healthcare.
Through pioneering research, cutting-edge technology, and a deep understanding of the unique needs of each young patient, the partnership ushers in a new era of paediatric care – one that transcends traditional boundaries and promises a future where every child in Canada receives healthcare that is as unique as their own DNA.